Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David L. Grange currently holds 22,700 shares of PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David L. Grange has been a net seller of PPDI stock. They have purchased $0 and sold $3.4M worth of shares.
David L. Grange's most recent insider trade was on May 12, 2026, when they sold 22,700 shares at $0.00 per share.
David L. Grange serves as Executive at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI). They have executed 29 insider transactions totaling $3.4M over their tenure at the company.
David L. Grange holds the position of Executive at PHARMACEUTICAL PRODUCT DEVELOPMENT INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David L. Grange has shown a selling trading pattern, with $0 in total purchases and $3.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David L. Grange was on Nov 3, 2010, when they sold $1.3M worth of PPDI shares. This transaction involved 51,380 shares at $25.71 per share.
David L. Grange currently owns 22,700 shares of PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David L. Grange's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David L. Grange has 29 Form 4 filings on record as an insider at PHARMACEUTICAL PRODUCT DEVELOPMENT INC.
Set alerts for David L. Grange and 40,000+ other insiders.